Company news
Allergy Therapeutics plc news in 2018
Allergy Therapeutics plc's news releases, calls and decks from 2018, newest first.
AGM Trading Update
November 27, 2018
Presentation at Jefferies Healthcare Conference
November 12, 2018
Directorate Change
November 8, 2018
Allergy Therapeutics (AGY): 2018 full-year resu...
September 27, 2018
Notice of Results
August 8, 2018
Results of Placing and Subscription
July 19, 2018
Proposed placing & subscription to raise £10.6m
July 19, 2018
Allergy Therapeutics (AGY): Steady performance...
July 13, 2018
Positive data of Pollinex Quattro Grass vaccine
June 25, 2018
Positive data with house-dust mite immunotherapy
May 29, 2018
Allergy Therapeutics (AGY): Opening the door to...
May 21, 2018
Positive top-line results from Grass Ph II study
May 21, 2018
Publication of MCT Adjuvant Data
May 14, 2018
Hardman: Clinical development towards submission
March 7, 2018
Polyvac® Peanut CMO appointed
February 28, 2018
Completion of recruitment in PQ Grass Ph II trial
February 12, 2018
Hardman Research: Growth in a tough market
February 2, 2018
PQ Birch Phase III trial completes recruitment
January 9, 2018
Decks in 2018
- H1 2018 Earnings Presentation
Earnings · 36 slides · March 2018